Clare Arnott's Publications

About Clare Arnott's Publications

Global Director, Cardiovascular Program
  • Co-Director, Global Chronic & Complex Diseases
  • BMed Sci,
  • MBBS (Hons),
  • PhD,
  • FRACP,
  • FESC,
  • CF

  • Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial

    Diabetologia Date published:

  • Sex Disparities in Sudden Cardiac Death

    Circulation: Arrhythmia and Electrophysiology Date published:

  • Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial

    The American Journal of Clinical Nutrition Date published:

  • Association of Baseline Diuretic Use With Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: A Secondary Analysis From TOPCAT

    Journal of Cardiac Failure Date published:

  • Guideline-Directed Medical Therapy in Females with Heart Failure with Reduced Ejection Fraction

    Current Heart Failure Reports Date published:

  • Why Are We Forgetting Patients With Peripheral Arterial Disease?

    Heart, Lung and Circulation Date published:

  • Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease

    Circulation Date published:

  • Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial

    Cardiovascular Research Date published:

  • The long-term cardiovascular impact of hypertension in pregnancy - A missed opportunity

    Australian and New Zealand Journal of Obstetrics and Gynaecology Date published:

  • Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

    The Lancet Date published:

  • An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials

    International Journal of Cardiology Date published:

  • Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program

    ESC Heart Failure Date published:

  • ELASTIC CHEST COMPRESSION REDUCED HYPERINFLATION IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Date published:

  • Cardiovascular Disease in Women: From Pathophysiology to Novel and Emerging Risk Factors

    Heart, Lung and Circulation Date published:

  • Canagliflozin and Cardiovascular Outcomes in Patients With and Without Peripheral Artery Disease At Baseline: Data from the CANVAS Program and CREDENCE Trials

    Heart, Lung and Circulation Date published:

  • Assessing knowledge of healthcare providers concerning cardiovascular risk after hypertensive disorders of pregnancy: an Australian national survey

    BMC Pregnancy and Childbirth Date published: